| Name | Title | Contact Details |
|---|
Serving Virginia's Eastern Shore with five medical centers and four dental locations from Chincoteague Island to Cape Charles, Eastern Shore Rural Health System, Inc. (ESRHS), is the medical provider of choice for more than half the Eastern Shore community's population. All ESRHS centers are open Monday - Friday with evening hours available including 10-hour days at the Onley center. ESRHS is open on Saturday mornings year-round at the Onley center and seasonally at Chincoteague. In addition to primary medical and dental services, ESRHS offers health education, pharmacy assistance, digital x-ray, labwork, travel immunizations and much, much more. In partnership with the Chesapeake Bay Bridge-Tunnel, ESRHS is able to offer toll passes for qualifying residents who have a medical visit with a specialist. ESRHS' electronic health records system means you can be seen at any ESRHS center and the staff will have your complete medical history. ESRHS' highly qualified clinicians offer compassionate, dedicated care for their patients. At ESRHS you are more than just a medical chart, you're a part of a family-oriented medical home. In one year's time 28,483 people chose one of Rural Health's five medical locations or four dental locations for their healthcare needs. We provided 92,712 medical and 13,606 dental visits. This past fiscal year, 29% of Rural Health patients had private insurance; 19% had Medicaid; 14% had Medicare; and 38% were uninsured.
Quality Packaging L L C is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Burlington, NJ. To find more information about Quality Packaging L L C, please visit www.qpsiusa.com
Chinese Community Health Plan is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
EcoNugenics® was founded in 1995 by Dr. Isaac Eliaz, M.D., M.S., L.Ac. - a pioneer and expert in the field of integrative medicine, and a highly regarded clinical practitioner, formulator, researcher and author. Dr. Eliaz leads our research activities in natural, integrative approaches to cellular, immune, metabolic, digestive, and cardiovascular health, as well as detoxification.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.